Roche is making a big bet on fatty liver disease, announcing a $2.4B acquisition of 89bio to secure rights to…
Browsing: Clinical Updates
In this Medscape commentary, Dr. Scott Kopetz of MD Anderson unpacks the rising role of ctDNA in colorectal cancer. Unlike…
Researchers at the University of Geneva have catalogued gut bacteria at the subspecies level and, with machine learning, trained a…
Medscape reports that oral GLP-1 drugs may reshape the obesity treatment landscape, but their true impact remains uncertain. With Novo…
The FDA has approved the Idylla CDx MSI test, a fully automated companion diagnostic for colorectal cancer that delivers results…
Early-onset gastrointestinal cancers are rising at alarming rates in adults under 50, yet most remain outside screening protocols—leaving vague symptoms…
Colonoscopy is evolving beyond a diagnostic tool—mechanical add-ons like the Endocuff are quietly boosting adenoma detection rates, a key factor…
Guardant Health is taking its FDA-approved Shield™ blood test for colorectal cancer into senior living communities through a new partnership…
Two new studies in Clinical Gastroenterology and Hepatology and Gastroenterology reveal just how powerfully the gut-brain connection shapes our eating…
Exact Sciences has launched Cancerguard™, a $689 multi-cancer early detection (MCED) blood test now available nationwide through Quest Diagnostics. Cancerguard…